loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2265435 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN ASPART (1)

02 INSULIN ASPART PROTAMINE (1)

filter

01 NOVO NORDISK CANADA INC (2)

filter

01 SUSPENSION (2)

filter

01 30UNIT/ML (1)

02 70UNIT/ML (1)

filter

01 Canada (2)

URL Supplier Web Content
SUSPENSION
70UNIT/ML
NOVOMIX 30
Canada
2265435
3ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION
30UNIT/ML
NOVOMIX 30
Canada
2265435
3ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2265435

Looking for CTD TGA MCC DOSSIER APPLICATION 2265435 2

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART PROTAMINE, with a corresponding application number 2265435 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOMIX 30 SUSPENSION, medication with 70UNIT/ML of INSULIN ASPART PROTAMINE.

18

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART, with a corresponding application number 2265435 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOMIX 30 SUSPENSION, medication with 30UNIT/ML of INSULIN ASPART.

Post Enquiry
POST ENQUIRY